カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/10 | 1,137 | 1,153 | 1,137 | 1,140 | +4 | +0.4% | 7,500 |
| 2024/06/07 | 1,147 | 1,151 | 1,136 | 1,136 | -17 | -1.5% | 4,200 |
| 2024/06/06 | 1,147 | 1,154 | 1,142 | 1,153 | ±0 | ±0% | 1,300 |
| 2024/06/05 | 1,145 | 1,154 | 1,141 | 1,153 | +8 | +0.7% | 3,200 |
| 2024/06/04 | 1,138 | 1,156 | 1,137 | 1,145 | +7 | +0.6% | 2,700 |
| 2024/06/03 | 1,135 | 1,158 | 1,130 | 1,138 | +2 | +0.2% | 11,700 |
| 2024/05/31 | 1,139 | 1,151 | 1,136 | 1,136 | -3 | -0.3% | 1,900 |
| 2024/05/30 | 1,152 | 1,152 | 1,136 | 1,139 | -3 | -0.3% | 1,600 |
| 2024/05/29 | 1,145 | 1,154 | 1,142 | 1,142 | -3 | -0.3% | 5,300 |
| 2024/05/28 | 1,129 | 1,158 | 1,129 | 1,145 | +7 | +0.6% | 3,300 |
| 2024/05/27 | 1,131 | 1,141 | 1,131 | 1,138 | -1 | -0.1% | 2,700 |
| 2024/05/24 | 1,135 | 1,149 | 1,135 | 1,139 | -1 | -0.1% | 700 |
| 2024/05/23 | 1,149 | 1,157 | 1,138 | 1,140 | -9 | -0.8% | 6,300 |
| 2024/05/22 | 1,153 | 1,153 | 1,144 | 1,149 | -4 | -0.3% | 1,300 |
| 2024/05/21 | 1,159 | 1,159 | 1,143 | 1,153 | -6 | -0.5% | 2,300 |
| 2024/05/20 | 1,148 | 1,160 | 1,134 | 1,159 | +11 | +1% | 5,500 |
| 2024/05/17 | 1,132 | 1,149 | 1,130 | 1,148 | +5 | +0.4% | 1,600 |
| 2024/05/16 | 1,141 | 1,149 | 1,132 | 1,143 | +3 | +0.3% | 1,300 |
| 2024/05/15 | 1,130 | 1,164 | 1,120 | 1,140 | +7 | +0.6% | 27,000 |
| 2024/05/14 | 1,142 | 1,144 | 1,133 | 1,133 | -12 | -1% | 3,500 |
| 2024/05/13 | 1,152 | 1,164 | 1,140 | 1,145 | -7 | -0.6% | 11,800 |
| 2024/05/10 | 1,138 | 1,155 | 1,134 | 1,152 | +19 | +1.7% | 17,900 |
| 2024/05/09 | 1,230 | 1,245 | 1,131 | 1,133 | -89 | -7.3% | 74,000 |
| 2024/05/08 | 1,214 | 1,223 | 1,214 | 1,222 | +8 | +0.7% | 1,100 |
| 2024/05/07 | 1,199 | 1,224 | 1,199 | 1,214 | +6 | +0.5% | 6,400 |
| 2024/05/02 | 1,196 | 1,208 | 1,196 | 1,208 | +8 | +0.7% | 900 |
| 2024/05/01 | 1,202 | 1,209 | 1,200 | 1,200 | -2 | -0.2% | 1,800 |
| 2024/04/30 | 1,212 | 1,212 | 1,195 | 1,202 | -10 | -0.8% | 9,200 |
| 2024/04/26 | 1,201 | 1,212 | 1,191 | 1,212 | +2 | +0.2% | 3,400 |
| 2024/04/25 | 1,225 | 1,227 | 1,203 | 1,210 | -1 | -0.1% | 16,700 |
| 2024/04/24 | 1,202 | 1,211 | 1,202 | 1,211 | +7 | +0.6% | 1,900 |
| 2024/04/23 | 1,200 | 1,219 | 1,200 | 1,204 | +12 | +1% | 4,100 |
| 2024/04/22 | 1,190 | 1,205 | 1,190 | 1,192 | +7 | +0.6% | 2,200 |
| 2024/04/19 | 1,202 | 1,206 | 1,170 | 1,185 | -17 | -1.4% | 7,500 |
| 2024/04/18 | 1,209 | 1,209 | 1,197 | 1,202 | -9 | -0.7% | 800 |
| 2024/04/17 | 1,204 | 1,213 | 1,181 | 1,211 | +2 | +0.2% | 3,300 |
| 2024/04/16 | 1,210 | 1,229 | 1,205 | 1,209 | -1 | -0.1% | 2,000 |
| 2024/04/15 | 1,218 | 1,229 | 1,210 | 1,210 | -8 | -0.7% | 1,600 |
| 2024/04/12 | 1,228 | 1,228 | 1,200 | 1,218 | -2 | -0.2% | 6,300 |
| 2024/04/11 | 1,214 | 1,228 | 1,208 | 1,220 | ±0 | ±0% | 2,100 |
| 2024/04/10 | 1,231 | 1,232 | 1,218 | 1,220 | -11 | -0.9% | 3,100 |
| 2024/04/09 | 1,217 | 1,240 | 1,210 | 1,231 | +1 | +0.1% | 3,200 |
| 2024/04/08 | 1,220 | 1,230 | 1,204 | 1,230 | +10 | +0.8% | 6,900 |
| 2024/04/05 | 1,219 | 1,220 | 1,193 | 1,220 | ±0 | ±0% | 6,400 |
| 2024/04/04 | 1,190 | 1,220 | 1,190 | 1,220 | +31 | +2.6% | 6,000 |
| 2024/04/03 | 1,186 | 1,194 | 1,161 | 1,189 | +1 | +0.1% | 4,100 |
| 2024/04/02 | 1,185 | 1,192 | 1,173 | 1,188 | +2 | +0.2% | 2,300 |
| 2024/04/01 | 1,197 | 1,198 | 1,160 | 1,186 | -11 | -0.9% | 9,300 |
| 2024/03/29 | 1,202 | 1,217 | 1,191 | 1,197 | -12 | -1% | 4,700 |
| 2024/03/28 | 1,220 | 1,221 | 1,181 | 1,209 | -13 | -1.1% | 5,000 |
201～
250
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 118,400円 | +6.8% | -13.8% | 2.96% | 9.07倍 | 0.77倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| モダリス | 7,800円 | - | - | 0.00% | - | 1.63倍 |
|
遺伝子治療薬の創薬ベンチャー、ＤＮＡ切断しないエピゲノム編集に強み。研究開発中心は米国 |
| ティムス | 14,200円 | - | - | 0.00% | - | 1.93倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国ＣＯＲＸＥＬ社に導出 |
| クリングル | 78,700円 | +240.0% | - | 0.00% | - | 2.58倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| カルナバイオ | 25,900円 | +13.5% | - | 0.00% | - | 2.00倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム
